Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, including urinary urgency incontinence and urinary urgency frequency, fecal incontinence, and urinary retention. Its proprietary r-SNM System delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of urinary and fecal dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was founded in 2012 and is based in Irvine, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone949-396-6322
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$710,000.00
Profitability
Miscellaneous
Employees87
Next Earnings Date12/10/2019 (Estimated)
OptionableNot Optionable
Axonics Modulation Technologies (NASDAQ:AXNX) Frequently Asked Questions
What is Axonics Modulation Technologies' stock symbol?
Axonics Modulation Technologies trades on the NASDAQ under the ticker symbol "AXNX."
How were Axonics Modulation Technologies' earnings last quarter?
Axonics Modulation Technologies Inc (NASDAQ:AXNX) posted its earnings results on Monday, August, 5th. The company reported ($0.68) EPS for the quarter, missing the consensus estimate of ($0.51) by $0.17. The business had revenue of $1.49 million for the quarter, compared to analyst estimates of $1.04 million. Axonics Modulation Technologies had a negative return on equity of 59.67% and a negative net margin of 1,515.61%. The company's revenue was up 12300.0% on a year-over-year basis. View Axonics Modulation Technologies' Earnings History.
When is Axonics Modulation Technologies' next earnings date?
What price target have analysts set for AXNX?
7 analysts have issued 12-month target prices for Axonics Modulation Technologies' stock. Their predictions range from $14.92 to $47.00. On average, they expect Axonics Modulation Technologies' stock price to reach $38.27 in the next year. This suggests a possible upside of 87.3% from the stock's current price. View Analyst Price Targets for Axonics Modulation Technologies.
What is the consensus analysts' recommendation for Axonics Modulation Technologies?
Has Axonics Modulation Technologies been receiving favorable news coverage?
News headlines about AXNX stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Axonics Modulation Technologies earned a news sentiment score of -1.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Axonics Modulation Technologies.
Are investors shorting Axonics Modulation Technologies?
Axonics Modulation Technologies saw a increase in short interest in September. As of September 15th, there was short interest totalling 2,680,000 shares, an increase of 8.1% from the August 15th total of 2,480,000 shares. Based on an average daily trading volume, of 246,900 shares, the days-to-cover ratio is presently 10.9 days. Currently, 28.0% of the company's shares are sold short. View Axonics Modulation Technologies' Current Options Chain.
Who are some of Axonics Modulation Technologies' key competitors?
Some companies that are related to Axonics Modulation Technologies include Glaukos (GKOS), Cardiovascular Systems (CSII), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Atrion (ATRI), Inspire Medical Systems (INSP), AtriCure (ATRC), Silk Road Medical (SILK), Orthofix Medical (OFIX), Luminex (LMNX), Tactile Systems Technology (TCMD), Shockwave Medical (SWAV), Cryolife (CRY), Anika Therapeutics (ANIK) and LeMaitre Vascular (LMAT).
What other stocks do shareholders of Axonics Modulation Technologies own?
Who are Axonics Modulation Technologies' key executives?
Axonics Modulation Technologies' management team includes the folowing people:
- Mr. Raymond W. Cohen, CEO & Director (Age 60)
- Mr. Danny L. Dearen, Pres & CFO (Age 56)
- Dr. Karen L. Noblett M.D., M.A.S., Chief Medical Officer (Age 56)
- Mr. Rinda K. Sama, Chief Operating Officer (Age 40)
- Mr. Guangqiang Jiang Ph.D., Chief Technology Officer (Age 46)
When did Axonics Modulation Technologies IPO?
(AXNX) raised $100 million in an IPO on Wednesday, October 31st 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Morgan Stanley acted as the underwriters for the IPO and Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.
How do I buy shares of Axonics Modulation Technologies?
Shares of AXNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Axonics Modulation Technologies' stock price today?
One share of AXNX stock can currently be purchased for approximately $20.44.
How big of a company is Axonics Modulation Technologies?
Axonics Modulation Technologies has a market capitalization of $583.05 million and generates $710,000.00 in revenue each year. The company earns $-32,480,000.00 in net income (profit) each year or ($4.64) on an earnings per share basis. Axonics Modulation Technologies employs 87 workers across the globe.View Additional Information About Axonics Modulation Technologies.
What is Axonics Modulation Technologies' official website?
How can I contact Axonics Modulation Technologies?
Axonics Modulation Technologies' mailing address is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. The company can be reached via phone at 949-396-6322.
MarketBeat Community Rating for Axonics Modulation Technologies (NASDAQ AXNX)
MarketBeat's community ratings are surveys of what our community members think about Axonics Modulation Technologies and other stocks. Vote "Outperform" if you believe AXNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
